Please use a PC Browser to access Register-Tadawul
Sangamo Therapeutics Announces Postponement Of First Quarter 2025 Conference Call To 6:30PM Eastern May12 ,2025
Sangamo BioSciences, Inc. SGMO | 0.50 | -3.08% |
Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced that the first quarter earnings call originally scheduled for 4:30p.m. Eastern on Monday, May 12 will be postponed to 6:30p.m. Eastern on Monday, May 12, 2025.
The registration and access link previously provided remains the same.
Participants should register for, and access, the call using this link. While not required, it is recommended to join 10 minutes prior to the event start. Once registered, participants will be given the option to either dial into the call with the number and unique passcode provided, or to use the dial-out option to connect their phone instantly. The link to access the live webcast can also be found on the Sangamo Therapeutics website in the Investors and Media section under Events.
A replay will be available following the conference call, accessible under Events.